Breaking News

PAREXEL, NTUH in Taiwan Services Alliance

November 27, 2012

Aims to drive greater efficiency for sponsors in the Asia-Pac region

PAREXEL and the National Taiwan University Hospital (NTUH) have established an alliance to provide drug development services in Taiwan. The alliance aims to drive greater efficiency for biopharma sponsors though NTUH’s center of excellence for clinical trials in Taiwan and the support of PAREXEL’s clinical development services to local and global companies.
 
“Partnering with National Taiwan University Hospital further enhances our ability to meet the increasing demand from our clients to provide a full scope of Phase I-IV clinical trials in a rapidly growing market,” said Joe Avellone, M.D., corporate senior vice president, Clinical Research Services, PAREXEL. “The National Taiwan University Hospital is well-known and highly respected in Taiwan. We are pleased to have the opportunity to work together to advance our biopharmaceutical clients' programs in the region and help them to compete more effectively in the global marketplace.”

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research